SORIATANE
Identification of Soriatane
| No description |
Google image searchProduct monograph
Active ingredient
acitretin, 25 MG
DIN: 02070863
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: ALLERGAN INC
Date: 20-MAR-2020
ATC:
- D05 — ANTIPSORIATICS (ATC, ATC/DDD, )
- D05B — ANTIPSORIATICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- D05BB — Retinoids for treatment of psoriasis (ATC, ATC/DDD)
- D05BB02 — ACITRETIN (ATC/DDD)
Reference brand drug: Soriatane
